| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39,970 |
36,635 |
$1.18M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,397 |
18,418 |
$694K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,235 |
3,037 |
$168K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,186 |
3,114 |
$142K |
| 96158 |
|
2,612 |
2,111 |
$141K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,272 |
2,199 |
$110K |
| 80050 |
General health panel |
2,439 |
2,421 |
$86K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,029 |
1,015 |
$85K |
| 90686 |
|
4,405 |
4,304 |
$85K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,067 |
2,038 |
$78K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
656 |
648 |
$66K |
| 96156 |
|
819 |
778 |
$59K |
| 90698 |
|
1,791 |
1,741 |
$38K |
| 90670 |
|
1,756 |
1,717 |
$37K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,368 |
1,350 |
$36K |
| 36415 |
Collection of venous blood by venipuncture |
10,517 |
9,768 |
$36K |
| 94760 |
|
11,413 |
10,814 |
$29K |
| 96127 |
|
5,421 |
5,108 |
$28K |
| 96152 |
|
699 |
587 |
$27K |
| 80053 |
Comprehensive metabolic panel |
3,593 |
3,489 |
$26K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
320 |
320 |
$22K |
| 80061 |
Lipid panel |
2,148 |
2,131 |
$20K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,632 |
1,605 |
$19K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,558 |
3,441 |
$19K |
| 83721 |
|
2,557 |
2,527 |
$19K |
| 90688 |
|
1,032 |
981 |
$18K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
677 |
657 |
$18K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
758 |
756 |
$16K |
| 96160 |
|
4,868 |
4,562 |
$15K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,032 |
2,007 |
$14K |
| 82728 |
|
1,387 |
1,380 |
$13K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
474 |
466 |
$11K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
474 |
466 |
$11K |
| 96150 |
|
554 |
477 |
$10K |
| 90680 |
|
385 |
374 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
359 |
344 |
$8K |
| 84439 |
|
1,163 |
1,136 |
$8K |
| 90651 |
|
309 |
302 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,188 |
1,150 |
$7K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
647 |
629 |
$7K |
| 93000 |
|
371 |
371 |
$6K |
| 99177 |
|
2,340 |
2,311 |
$5K |
| 90656 |
|
263 |
261 |
$5K |
| 99215 |
Prolong outpt/office vis |
32 |
31 |
$5K |
| 90677 |
|
218 |
215 |
$5K |
| 0071A |
|
110 |
109 |
$4K |
| 90744 |
|
192 |
185 |
$4K |
| 0072A |
|
98 |
98 |
$4K |
| 0002A |
|
79 |
78 |
$3K |
| 0001A |
|
78 |
78 |
$3K |
| 90734 |
|
122 |
120 |
$3K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
188 |
177 |
$3K |
| 81001 |
|
1,210 |
1,178 |
$3K |
| 83550 |
|
440 |
439 |
$3K |
| 90633 |
|
108 |
108 |
$2K |
| 83540 |
|
467 |
466 |
$2K |
| 90710 |
|
97 |
97 |
$2K |
| 90672 |
|
92 |
92 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
115 |
111 |
$2K |
| 82607 |
|
154 |
154 |
$2K |
| 87634 |
|
29 |
29 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
224 |
216 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
108 |
53 |
$1K |
| 0011A |
|
45 |
39 |
$1K |
| 86703 |
|
134 |
133 |
$1K |
| 86140 |
|
346 |
344 |
$1K |
| 0012A |
|
37 |
34 |
$1K |
| 85652 |
|
603 |
599 |
$1K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
13 |
13 |
$821.40 |
| 0064A |
|
37 |
31 |
$681.55 |
| 99443 |
|
21 |
18 |
$651.25 |
| 97802 |
|
14 |
13 |
$614.67 |
| 87210 |
|
137 |
134 |
$537.24 |
| 86780 |
|
55 |
55 |
$472.77 |
| 84450 |
|
128 |
124 |
$461.01 |
| 82040 |
|
116 |
113 |
$399.05 |
| 82570 |
|
109 |
109 |
$395.89 |
| 81015 |
|
171 |
167 |
$393.79 |
| 84075 |
|
109 |
106 |
$392.04 |
| 83718 |
|
68 |
68 |
$372.45 |
| 82247 |
|
105 |
90 |
$361.53 |
| 84155 |
|
125 |
122 |
$321.25 |
| 90685 |
|
14 |
14 |
$285.48 |
| 82465 |
|
94 |
94 |
$271.45 |
| 90715 |
|
12 |
12 |
$263.52 |
| 90619 |
|
14 |
12 |
$263.52 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
12 |
$253.81 |
| 85007 |
|
115 |
113 |
$250.31 |
| 85027 |
|
53 |
51 |
$238.95 |
| 84460 |
|
61 |
59 |
$226.31 |
| 82043 |
|
43 |
43 |
$162.00 |
| 96159 |
|
14 |
12 |
$124.69 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
14 |
14 |
$58.80 |
| 83690 |
|
14 |
14 |
$57.84 |
| 90473 |
|
15 |
15 |
$45.42 |
| 3078F |
|
45,495 |
41,737 |
$0.00 |
| 3288F |
|
12 |
12 |
$0.00 |
| 91300 |
|
174 |
167 |
$0.00 |
| 3077F |
|
59 |
56 |
$0.00 |
| 1090F |
|
13 |
13 |
$0.00 |
| 3074F |
|
52,669 |
47,992 |
$0.00 |
| 3075F |
|
285 |
269 |
$0.00 |
| 3080F |
|
61 |
54 |
$0.00 |
| 3008F |
|
36,105 |
33,311 |
$0.00 |
| 3044F |
|
540 |
522 |
$0.00 |
| 3079F |
|
5,438 |
5,073 |
$0.00 |
| 99000 |
|
6,470 |
6,108 |
$0.00 |
| 91307 |
|
99 |
99 |
$0.00 |
| 91301 |
|
99 |
98 |
$0.00 |
| 91306 |
|
12 |
12 |
$0.00 |